AAM
BSX icon

Aberdeen Asset Management’s Boston Scientific BSX Stock Holding History

Aberdeen Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$7.75M Sell
279,652
-226,073
-45% -$6M 0.03% 398
2017
Q1 		$12.6M Sell
505,725
-401,601
-44% -$9.77M 0.04% 302
2016
Q4 		$19.6M Sell
907,326
-53,733
-6% -$1.17M 0.08% 229
2016
Q3 		$22.9M Sell
961,059
-11,787
-1% -$281K 0.08% 202
2016
Q2 		$22.7M Sell
972,846
-86,173
-8% -$1.86M 0.08% 188
2016
Q1 		$19.9M Sell
1,059,019
-64,099
-6% -$1.13M 0.07% 189
2015
Q4 		$18.4M Buy
1,123,118
+35,036
+3% +$628K 0.06% 195
2015
Q3 		$17.9M Sell
1,088,082
-23,341
-2% -$399K 0.06% 173
2015
Q2 		$19.7M Sell
1,111,423
-47,425
-4% -$847K 0.06% 176
2015
Q1 		$20.6M Sell
1,158,848
-153,878
-12% -$2.43M 0.06% 180
2014
Q4 		$17.4M Sell
1,312,726
-158,130
-11% -$2.02M 0.04% 203
2014
Q3 		$17.4M Buy
1,470,856
+225,085
+18% +$2.83M 0.04% 232
2014
Q2 		$15.9M Buy
+1,245,771
New +$16.2M 0.03% 261

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Aberdeen Asset Management's BSX Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Boston Scientific (BSX) stake by 45% in Q2 2017, selling an estimated $6M and leaving 279,652 shares worth $7.75M. The position accounts for 0.03% of the portfolio, ranked #398.

Aberdeen Asset Management first reported a position in BSX in Q2 2014 and has held it in 13 quarters since. The position peaked at $22.9M in Q3 2016. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Aberdeen Asset Management held 279,652 shares of Boston Scientific worth $7.75M as of Q2 2017.
  • Aberdeen Asset Management sold 226,073 Boston Scientific shares in Q2 2017, an estimated $6M.
  • Boston Scientific made up 0.03% of Aberdeen Asset Management's portfolio in Q2 2017, its #398 holding.
  • Aberdeen Asset Management first reported a position in Boston Scientific in Q2 2014 and has held it in 13 quarters since.
  • Aberdeen Asset Management's Boston Scientific position peaked at $22.9M in Q3 2016.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.